CCR Trends Report 2022: Taking the Lead in Topicals

CCR (Clinical + Cosmetic + Regenerative) is the biggest aesthetic conference in the UK showcasing the industries most innovative and effective technologies.

CCRs annual trends report and press conference discusses the medical aesthetics industry's newest and most noteworthy trends in surgical and non-surgical aesthetics. ​

This years trends report paid attention to game-changing topical skincare.

Topicals Taking the Lead

Evenswiss, a cosmeceutical range powered by patented technology and 6 clinical studies, was selected for this years report.

"An exciting array of non-injectable products that are sure to hit headlines this year"

"An exciting new patented technology called Dermatopoietin is enhancing skincare results by up to 90% in two weeks. ​ By mimicking a natural signaling cytokine found in the skin, Dermatopoietin, found exclusively in Evenswiss skincare triggers a surge of collagen, elastin, and hyaluronic acid production. Thanks to this, clinical studies have shown improvements in fine lines and wrinkles, skin density, under eye bags, cellulite and hair loss." ​

- Excerpt from CCRs Trends Report - Co-edited by Francesca White, Beauty Editor at-large Tatler Magazine, and Shannon Kilgriff, Aesthetics Journal Editor & content manager.

Praise by Top Aesthetic Surgeons

"We're delighted to be able to offer our patients Evenswiss products via Get Harley. The brand has already developed a cult following amongst our patients who have found noticeable reduction in redness and puffiness of the under-eye area with the Rejuvenating Eye Complex & rejuvenating serum as early as two weeks of use.

The combination of Dermatopoietin (IL-1a) a polypeptide involved in modulation of inflammation and cell signaling and probiotic helps to keep dark puffy under-eye circles at bay and protect from blue light damage"

-Dr Rachna Murthy (Consultant Oculoplastic &Aesthetic Surgeon, Co-director FaceRestoration)

Why it Works

Conventional anti-aging products are limited by the poor penetration of the skin barrier, and therefore, have minor effects in the dermis. ​ They include chemical penetration enhancers which can facilitate the penetration of pollutants and microorganisms into the skin.

Dermatopoietin is a first-of-its-kind technology that does not need to penetrate the skin in order to work. ​

The technology gives a message to outer skin cells which allows them to generate internal signals in the skin and trigger regeneration. This gives extreme and long-term results.

Press Contact

Nicole Gonzalez, Head of PR at Dermoi

press@dermoi.com

Dermoi is a platform for the latest achievements in skincare, all in one place. ​

Every product is selected and endorsed by in-house scientists.